Lindbrook Capital’s Spectrum Pharmaceuticals SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1
| Closed | -$1 | – | 2869 |
|
|
2023
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 2703 |
|
|
2023
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 2769 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3057 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2995 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2858 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | +$1 | ﹤0.01% | 2658 |
|
|
2021
Q3 | – | Sell |
-625
| Closed | -$2K | – | 2040 |
|
|
2021
Q2 | $2K | Buy |
625
+285
| +84% | +$990 | ﹤0.01% | 1677 |
|
|
2021
Q1 | $1K | Sell |
340
-448
| -57% | -$1.61K | ﹤0.01% | 1834 |
|
|
2020
Q4 | $3K | Hold |
788
| – | – | ﹤0.01% | 1395 |
|
|
2020
Q3 | $3K | Buy |
788
+448
| +132% | +$1.7K | ﹤0.01% | 1331 |
|
|
2020
Q2 | $1K | Buy |
+340
| New | +$991 | ﹤0.01% | 1667 |
|
Lindbrook Capital's SPPI Position: Q3 2023 in Review
Lindbrook Capital sold out of Spectrum Pharmaceuticals (SPPI) in Q3 2023, closing a stake of 1 share — an estimated $1 sold.
Lindbrook Capital first reported a position in SPPI in Q2 2020 and held it in 11 quarters. The position peaked at $3K in Q4 2020. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Lindbrook Capital reported no remaining Spectrum Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
- Lindbrook Capital sold 1 Spectrum Pharmaceuticals share in Q3 2023, an estimated $1.
- Lindbrook Capital first reported a position in Spectrum Pharmaceuticals in Q2 2020 and held it in 11 quarters.
- Lindbrook Capital's Spectrum Pharmaceuticals position peaked at $3K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals as of Q3 2023.
Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.